Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hind M. Alosaimi"'
Autor:
Hind M. Alosaimi, Mohammed K. Alshammari, Mohammad M. Fetyani, Maha S. Allehidan, Tahani J. Almalki, Khansa H. Hussain, Haifaa H. Hussain, Mohammed D. Althobaiti, Abrar S. Alharbi, Atheer A. Alharthi, Amosha A. Al-shammari, Zainab A. Al Jamea, Rayed A. Alamro, Ali Najmi
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
Background Neonates and children are more susceptible to a variety of infections, leading to frequent antibiotic prescriptions. However, the inappropriate use of antibiotics leads to antibiotic resistance and higher mortality rates. Therefore, this s
Externí odkaz:
https://doaj.org/article/a852ffc71027483692c6bb4a877303f5
Autor:
Hind M. Alosaimi, Rshed A. Alwatban, Haifa M. Alshammari, Ahmed H. Alshammari, Shatha S. Alanazi, Meshal A. Alreshidi, Abeer A. Alreshidi, Abrar S. Alsayed, Furat A. Alfaraj, Kawther A. Alzayer, Aymen A. Alzaher, Khawla M. Almutairi, Manar S. Almutairi, Reema H. Aljasir, Mohammed K. Alshammari
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
ABSTRACTIntroduction Chronic kidney disease (CKD) is a major public health concern in Saudi Arabia. it is pertinent to mention that in the Southwestern region of Saudi Arabia. Hypertension and diabetes mellites are considered the major drivers of CKD
Externí odkaz:
https://doaj.org/article/471ee8e7bca947aea1bea62c0c6d82a8
Autor:
Hind M. AlOsaimi, Ali M. Alqahtani, Nadia M. Alanazi, Nouf N. Alotibi, Mohammed S. Alrazog, Hanoof A. Aljameel, Raghad M. Alshehri, Sarah J. Alhusayni, Mohammed K. Alshammari
Publikováno v:
Medicina, Vol 59, Iss 12, p 2050 (2023)
Background and Objectives: In 2020, one of the most important steps that were made was to give priority to the development of a COVID-19 vaccine to prevent the rising incidence of COVID-19 from continuing to rise. However, globally, there is a variab
Externí odkaz:
https://doaj.org/article/40e7706eecfd4162913b7115b6a834a5
Autor:
Hind M. Alosaimi, Saeed Alqahtani, Bander Balkhi, Mishari Alqahtani, Faisal Alzamil, Abdulaziz Alhossan, Fatmah S. Alqahtany, Abdullah A. Alharbi, Nawaf Abdullah Alqahtani, Hanan Albackr, Ghada Elgohary, Farjah H. Algahtani
Publikováno v:
PeerJ, Vol 10, p e13974 (2022)
Background Real-world evidence on factor Xa inhibitor (rivaroxaban) prescribing patterns, safety, and efficacy in patients with non-valvular atrial fibrillation (NVAF) and venous thromboembolism (VTE) is rare. Herein, we sought to examine the above o
Externí odkaz:
https://doaj.org/article/ee21837d351149a38095892f0aac431c
Autor:
Salem Alkaabi, Osama E. Elkhateeb, Amin Daoulah, Mamdouh Haddara, Ayman S. Abougalambo, Ciaran M. Dixon, Hind M. Alosaimi, Alawi A. Alsheikh-Ali, Amir Lotfi, Mohamed Nabil Alama, Salem M. Al-Faifi, Ahmed Moustafa Elimam, Khalid S. Asiri, Waheed Murad, Mushabab Al-Murayeh
Publikováno v:
Coronary Artery Disease. 28:98-103
The aim of this study was to assess the association of widowhood with the severity and extent of coronary artery disease (CAD), and whether it is modified by sex or socioeconomic status.A total of 1068 patients undergoing coronary angiography at five
Autor:
Hind M. Alosaimi, Amir Lotfi, Mushabab Al-Murayeh, Mohamed Nabil Alama, Alawi A. Alsheikh-Ali, Amin Daoulah, Salem Alkaabi, Osama E. Elkhateeb, Sara Ocheltree, Salem M. Al-Faifi
Publikováno v:
Global Heart. 10:e23-e24